Literature DB >> 6952058

Acute intrinsic renal failure induced by indomethacin: role of prostaglandin synthetase inhibition.

J T McCarthy, V E Torres, J C Romero, D N Wochos, J A Velosa.   

Abstract

Nonsteroidal anti-inflammatory agents are often used to treat acute inflammatory arthritis because of their effectiveness and the infrequency of reported serious side effects. This report describes two patients who had acute intrinsic renal failure that was triggered by indomethacin. Both patients were volume contracted and had other circulatory impairments. Azotemia was so severe as to require temporary hemodialysis in one patient. Intrinsic renal function began to recover within 5 days after discontinuation of indomethacin. At the time that recovery began, urinary prostaglandin excretion increased in both patients. A detailed review of pertinent experimental data indicates that renal production of prostaglandin is an important compensatory response that helps to maintain renal function in the face of diminished renal blood flow. Our cases provide clinical support for this hypothesis and illustrate the fact that indomethacin, by interfering with this protective mechanism, can lead to acute intrinsic renal failure. Clinicians must be aware of this possible complication and use the nonsteroidal anti-inflammatory drugs with caution in patients who have compromised prerenal status.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6952058

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

1.  Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin.

Authors:  M J Webberley; J A Murray
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

2.  Antipyretic therapy in intensive care.

Authors:  D F Zandstra; C P Stoutenbeek
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

3.  Non-oliguric renal failure during treatment with mefenamic acid in elderly patients: a continuing problem.

Authors:  A Taha; R J Lenton; P S Murdoch; N R Peden
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-07

Review 4.  Side Effects of Indomethacin in Refractory Post-traumatic Intracranial Hypertension: A comprehensive case study and review.

Authors:  Daniel Agustín Godoy; Pablo David Guerrero Suarez; Luis Rafael Moscote-Salazar; Mario Di Napoli
Journal:  Bull Emerg Trauma       Date:  2017-07

Review 5.  Effects of non-narcotic analgesics on the kidney.

Authors:  P Kincaid-Smith
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 6.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 7.  Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.

Authors:  Mònica Vall-Palomar; Leire Madariaga; Gema Ariceta
Journal:  Pediatr Nephrol       Date:  2021-02-17       Impact factor: 3.714

Review 8.  Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19.

Authors:  Calum T Robb; Marie Goepp; Adriano G Rossi; Chengcan Yao
Journal:  Br J Pharmacol       Date:  2020-08-27       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.